title: Propranolol treatment for hemangioma of infancy.
abstract: Infantile hemangioma or hamangioma of infancy is the most common tumor in children, with great variability of presentation. Most cases resolve spontaneously and treatment is usually indicated for specific cases where injury has a high rate of morbidity or disfigurement after regression. The treatment is based on the use of systemic corticosteroids, which can also be used topically or by intralesional injections. Propranolol has been used recently as a new therapeutic option for the treatment of hemangiomas, with satisfactory, permanent results and fewer adverse effects than corticosteroids. This is a report of the case where a child presenting extensive periorbital and frontoparietal hemangioma was treated with propranolol.
authors: Universidade Estadual de Campinas, SP, Brasil. flabonini@gmail.com
authors: Flavia Kakiuti
authors: FK
authors: Bonini
authors: Fernanda Silva
authors: FS
authors: Bellodi
authors: Elemir Macedo
authors: EM
authors: Souza
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000008:administration & dosage*; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D011433:Propranolol